VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $786,633 | -10.3% | 29,232 | 0.0% | 0.18% | +11.3% |
Q2 2023 | $876,996 | -13.8% | 29,232 | -7.1% | 0.16% | -22.8% |
Q1 2023 | $1,017,957 | +0.8% | 31,467 | +20.9% | 0.21% | +4.0% |
Q4 2022 | $1,010,370 | +40.9% | 26,029 | -12.4% | 0.20% | -22.0% |
Q3 2022 | $717,000 | -74.1% | 29,707 | -70.5% | 0.25% | -65.9% |
Q2 2022 | $2,764,000 | -28.4% | 100,857 | +0.2% | 0.74% | +20.2% |
Q1 2022 | $3,861,000 | +273.4% | 100,670 | +212.4% | 0.62% | +324.7% |
Q4 2021 | $1,034,000 | +118.1% | 32,220 | +101.4% | 0.15% | +111.6% |
Q3 2021 | $474,000 | -64.8% | 16,000 | -57.2% | 0.07% | -68.5% |
Q4 2020 | $1,347,000 | -38.4% | 37,402 | -33.0% | 0.22% | -51.5% |
Q3 2020 | $2,187,000 | +62.0% | 55,800 | +51.6% | 0.45% | +22.5% |
Q2 2020 | $1,350,000 | -69.6% | 36,800 | -77.9% | 0.37% | -70.2% |
Q3 2019 | $4,447,000 | +6.2% | 166,500 | +1.6% | 1.24% | -7.2% |
Q2 2019 | $4,187,000 | +64.1% | 163,800 | +43.9% | 1.33% | +49.8% |
Q1 2019 | $2,551,000 | – | 113,800 | – | 0.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |